Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4677

Previous 25           Next 25
Website Changes
08/24/2015 ?Celldex and the limits of ‘overall survival benefit’ in cancer trials
08/24/2015 Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child-Resistant Closure Requirement
08/24/2015 NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing Patients In Trial Continuing To Be Treated Per Protocol, Including In Germany
08/24/2015 Update posted for Ben Williams` "Treatment Options for Glioblastoma and other Gliomas"
08/17/2015 San Diego couple trying to stop time with Novocure
08/17/2015 Added survivor story Debbie - 10 year GBM survivor!
08/14/2015 Cleveland Clinic researcher awarded National Cancer Institute`s Outstanding Investigator Award
08/14/2015 ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma
08/12/2015 Can a Lung Cancer Drug Fight Brain Tumors?
08/09/2015 Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
08/05/2015 Colchicine derivative as a potential anti-glioma compound.
08/05/2015 Musella Foundation Copayment Assistance Program is now closed to new patients
08/05/2015 IBTA e-News
07/27/2015 Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - FDA Evaluating the Risk of Brain Deposits With Repeated Use
07/27/2015 A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
07/18/2015 Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis.
07/18/2015 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.
07/18/2015 The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature.
07/18/2015 Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.
07/13/2015 Ottawa Hospital launches world`s first clinical trial of double-virus cancer treatment
07/13/2015 FDA Grants Fast Track Designation to Tocagen’s Toca 511 & Toca FC for Treatment of Recurrent High Grade Glioma
07/06/2015 Epigenetic Driver of Glioblastoma Provides New Therapeutic Target
07/06/2015 An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.
07/05/2015 Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
07/05/2015 Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.

Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites